Andrew Vaino, Ph.D. has been our Chief Scientific Officer since 2015. Dr. Vaino received his Ph.D. in chemistry from Queen’s University and his MBA from the University of California, Irvine.
Andrew Vaino, Ph.D. has been our Chief Scientific Officer since 2015. Dr. Vaino received his Ph.D. in chemistry from Queen’s University and his MBA from the University of California, Irvine.
All Rights Reserved.
© 2025 LB Pharmaceuticals. , a clinical-stage biopharmaceutical company developing novel therapies for the treatment of neuropsychiatric diseases, including schizophrenia.